Language Select
Varian Logo

Press Releases

January 08, 2018
Varian (NYSE: VAR) today announced it has signed a Memorandum of Understanding (MoU) with Ping An Health Technology Co., Ltd, to explore a strategic partnership for expanding access to cancer care... Read more
January 08, 2018
Varian (NYSE: VAR) today announced its Halcyon™ system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This approval further... Read more
January 03, 2018
Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss its transition to the new Accounting Standard Codification 606. No financial information concerning the just... Read more
December 28, 2017
Varian (NYSE: VAR) today announced the publication of its 2017 annual report. A PDF version of the Varian 2017 annual report is now available at: http://investors.varian.com/varianannualreports.... Read more
December 18, 2017
Varian (NYSE: VAR) today announced that Dow Wilson, president and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for 8:30... Read more
December 12, 2017
Varian (NYSE: VAR) today announced the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia has selected the Eclipse™ treatment planning system to replace its existing cancer... Read more
December 11, 2017
Varian (NYSE: VAR) today announced that it will report results for the first quarter of fiscal year 2018 after market close on Wednesday, January 24, 2018. The news release will be followed by a... Read more
December 06, 2017
Further expanding the global availability of its new device for cancer treatment, Varian (NYSE: VAR) today announced the Halcyon™ system has received ANVISA registration in Brazil. This... Read more
November 28, 2017
Varian Medical Systems (NYSE: VAR) announced today that its Board of Directors has scheduled the 2018 Annual Meeting of Stockholders for February 8, 2018 with a record date of December 11, 2017.... Read more
November 28, 2017
Varian (NYSE: VAR) today announced it is partnering with Penn Medicine to develop and launch a comprehensive proton therapy training and education program. Comprised of both online and in-person... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
VP, Investor Relations
650.424.5163
[email protected]